I'm a researcher whose groundbreaking work could potentially cure a rare genetic disease, but the only way to quickly secure enough funding to complete the trials is to partner with a pharmaceutical company known for exorbitant pricing and questionable ethics. Do I compromise my values for the greater good, or seek a slower, ethically sound path?

محمدعلی نجاتی